Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · FLGT · as of Sep 30, 2025
Ownership Breakdown
169
Institutional Holders
▼ 2 vs Q2
$389.32M
Total Inst. Value
▲ $66.09M vs Q2
28.40M
Shares Outstanding
freeFloat 61.86%
17.23M
13F Shares Held
▲ 967,832 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
FLGT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. services-medical laboratories | 2.98M | 9.65% | 9.65% | $67.24B | Nov 12, 2025 | ▲ 812.9K |
MILLENNIUM MANAGEMENT LLC services-medical laboratories | 1.47M | 4.76% | 4.76% | $33.20B | Nov 14, 2025 | ▲ 26.6K |
VANGUARD GROUP INC services-medical laboratories | 1.18M | 3.82% | 3.82% | $26.65B | Nov 7, 2025 | ▲ 13.3K |
ACADIAN ASSET MANAGEMENT LLC services-medical laboratories | 1.14M | 3.70% | 3.70% | $25.75B | Nov 13, 2025 | ▲ 22.2K |
DIMENSIONAL FUND ADVISORS LP services-medical laboratories | 1.13M | 3.68% | 3.68% | $25.61B | Nov 12, 2025 | ▼ 1.3K |
D. E. SHAW & CO., INC. services-medical laboratories | 567.8K | 1.84% | 1.84% | $12.83B | Nov 14, 2025 | ▲ 91.3K |
DEUTSCHE BANK AG\ services-medical laboratories | 504.5K | 1.64% | 1.64% | $11.40B | Nov 13, 2025 | ▲ 172.9K |
STATE STREET CORP services-medical laboratories | 502.0K | 1.63% | 1.63% | $11.35B | Nov 14, 2025 | ▼ 11.8K |
GEODE CAPITAL MANAGEMENT, LLC services-medical laboratories | 501.7K | 1.63% | 1.63% | $11.34B | Nov 12, 2025 | ▼ 11.7K |
AMERIPRISE FINANCIAL INC services-medical laboratories | 495.0K | 1.61% | 1.61% | $11.19B | Nov 14, 2025 | ▼ 3.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
32
Increased
+2.17M shares0
New Positions
first time holders17
Decreased
−680.6K shares0
Sold Out
fully exitedNet shares change (top 50)
+1.49M
+2.17M / −680.6K
Net new holders
+15
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
FLGT insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
7
Sell transactions
0.57
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Xie Jian President and COO | May 27, 2026 | Sale | 1,201 | $17.60 | $21.1K | 369.8K | Form 4 ↗ |
Kim Paul CFO and Treasurer | May 26, 2026 | Tax Withhold | 1,168 | $17.67 | $20.6K | 364.6K | Form 4 ↗ |
Gao Hanlin Chief Scientific Officer | May 27, 2026 | Sale | 945 | $17.60 | $16.6K | 992.1K | Form 4 ↗ |
Hsieh Ming Chief Executive Officer | May 26, 2026 | Tax Withhold | 2,949 | $17.67 | $52.1K | 897.7K | Form 4 ↗ |
Nohaile Michael director | May 14, 2026 | Award | 5,558 | — | — | 24.6K | Form 4 ↗ |
Nohaile Michael director | May 14, 2026 | Award | 8,426 | $16.19 | $136.4K | 8.4K | Form 4 ↗ |
Dong Linda director | May 14, 2026 | Award | 11,117 | — | — | 38.8K | Form 4 ↗ |
GROVES REGINA E director | May 14, 2026 | Award | 11,117 | — | — | 28.1K | Form 4 ↗ |
Gao Hanlin Chief Scientific Officer | Apr 26, 2026 | Tax Withhold | 1,645 | $16.31 | $26.8K | 993.0K | Form 4 ↗ |
Xie Jian President and COO | Apr 26, 2026 | Tax Withhold | 4,361 | $16.31 | $71.1K | 371.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Fulgent Genetics, Inc. (FLGT) is primarily owned by institutional investors, who hold approximately 60.7% of total shares outstanding. Company insiders own approximately 38.14%, while retail and public investors account for the remaining 1.20%.
The largest institutional shareholder of Fulgent Genetics, Inc. is BLACKROCK, INC., holding approximately 2.98 million shares — equal to 9.65% of outstanding shares — as of September 30, 2025.
A total of 169 institutional investors currently hold FLGT stock, with a combined institutional value of approximately $389,320,023 as of the most recent 13F filing period.
Frequently asked questions
FLGT ownershipFulgent Genetics, Inc. (FLGT) is primarily owned by institutional investors, who hold approximately 60.7% of shares. The largest shareholder is BLACKROCK, INC. with a 9.65% stake. Company insiders hold 38.14%. Data sourced from SEC Form 13F as of September 30, 2025.